If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,502.00    -109.00 (-2.36%)
Bid:
4,502.00
Ask:
4,503.00
Spread: 1.00 (0.022%)
Market Cap: £97.19b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Publication of a Prospectus

5 Mar 2024 16:30

RNS Number : 6470F
British American Tobacco PLC
05 March 2024

Publication of Prospectus

The following Base Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Base Prospectus dated 5 March 2024 (the "Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers (except where it is the relevant Issuer) (as Guarantors).

To view the Prospectus and certain documents incorporated by reference therein, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6470F_1-2024-3-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6470F_2-2024-3-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6470F_3-2024-3-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6470F_4-2024-3-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6470F_5-2024-3-5.pdf

The full documents will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Enquiries:

British American Tobacco Press Media Centre

+44 (0) 20 7845 2888 (24 hours) | @BATplc

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

Yetunde Ibe: +44 (0)20 7845 1095

John Harney: +44 (0)20 7845 1263

Jane Henderson: +44 (0)20 7845 1117

British American Tobacco p.l.c.Globe House4 Temple PlaceLondon WC2R 2PG

5 March 2024

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
PDIMZGGFMKGGDZM
Date   Source Headline
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20258:05 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:05 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202510:20 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 202510:40 amRNSDirector/PDMR Shareholding
11th Nov 202510:35 amRNSDirector/PDMR Shareholding
11th Nov 202510:30 amRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20253:15 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20252:45 pmRNSTotal Voting Rights
31st Oct 20252:45 pmRNSSubtantial Repurchase Event
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20259:15 amRNSResult of Tender Offer
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 202512:11 pmRNSPublication of a Prospectus
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20258:50 amRNSTender Offer
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 202510:30 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:05 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSDirectorate Change
13th Oct 202510:00 amRNSHolding(s) in Company
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:05 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSShare Buyback Programme
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.